As of 2026-04-21, the Fair Value of Charles River Laboratories International Inc (CRL) is -14.66 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 185.54 USD, the upside of Charles River Laboratories International Inc is -107.90%.
With the market price of 185.54 USD and our fair value calculation, Charles River Laboratories International Inc (CRL) is not a good investment. Investing in CRL stocks now will result in a potential loss of 107.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-25 | 2022-12-31 | 2023-12-30 | 2024-12-28 | 2025-12-27 | 5Y Avg | |
| Net income | 390.98 | 486.23 | 474.62 | 10.30 | -144.34 | 243.56 |
| YoY growth | 7.32% | 24.36% | -2.39% | -97.83% | -1,501.75% | -314.06% |
| Market Cap (mil) | 9,134.13 |
| P/E | |
| Forward P/E | 354.74x |
| EPS | -2.93 |
| Avg earnings growth rate | -314.06% |
| TTM earnings | -144.34 |